Advisor Group Holdings, Inc. Arbutus Biopharma Corp Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,338,516 shares of ABUS stock, worth $6.01 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,338,516
Previous 1,348,416
0.73%
Holding current value
$6.01 Million
Previous $4.17 Million
0.72%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding ABUS
# of Institutions
182Shares Held
118MCall Options Held
1MPut Options Held
478K-
Morgan Stanley New York, NY24.2MShares$108 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$59.9 Million14.31% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$51.9 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY10.4MShares$46.9 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$40.8 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $673M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...